Jazz Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
JAZZ Key Statistics
Stock Snapshot
As of today, Jazz Pharmaceuticals(JAZZ) shares are valued at $168.94. The company's market cap stands at 10.27B, with a P/E ratio of -27.96.
On 2025-12-08, Jazz Pharmaceuticals(JAZZ) stock moved within a range of $168.47 to $170.86. With shares now at $168.94, the stock is trading +0.3% above its intraday low and -1.1% below the session's peak.
Trading activity shows a volume of 862.09K, compared to an average daily volume of 1.11M.
Over the past 52 weeks, Jazz Pharmaceuticals(JAZZ) stock has traded between a high of $182.99 and a low of $95.49.
Over the past 52 weeks, Jazz Pharmaceuticals(JAZZ) stock has traded between a high of $182.99 and a low of $95.49.
JAZZ News
Jazz Pharmaceuticals announced that eight abstracts, including four late-breaking studies, on its approved epilepsy therapy Epidiolex were presented at the Amer...
